Phenotypic characterization of pncA mutants of Mycobacterium tuberculosis

被引:92
作者
Morlock, GP
Crawford, JT
Butler, WR
Brim, SE
Sikes, D
Mazurek, GH
Woodley, CL
Cooksey, RC
机构
[1] Ctr Dis Control & Prevent, Div AIDS STD & TB Lab Res, Natl Ctr Infect Dis, Atlanta, GA 30333 USA
[2] Ctr Dis Control & Prevent, Div TB Eliminat, Natl Ctr HUV STD & TB Prevent, Atlanta, GA 30333 USA
关键词
D O I
10.1128/AAC.44.9.2291-2295.2000
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We examined the correlation of mutations in the pyrazinamidase (PZase) gene (pncA) with the pyrazinamide (PZA) resistance phenotype with 60 Mycobacterium tuberculosis isolates. PZase activity was determined by the method of Wayne (L, G, Wayne, Am. Rev. Respir, Dis, 109:147-151, 1974), and the entire pncA nucleotide sequence, including the 74 bp upstream of the start codon, was determined. PZA susceptibility testing was performed by the method of proportions on modified Middlebrook and Cohn 7H10 medium. The PZA MICs were greater than or equal to 100 mu g/ml for 37 isolates, 34 of which had alterations in the pncA gene, These mutations included missense substitutions for 24 isolates, nonsense substitutions for 3 isolates, frameshifts by deletion for 4 isolates, a three codon insertion for 1 isolate, and putative regulatory mutations for 2 isolates. Among 21 isolates for which PZA MICs were <100 mu g/ml, 3 had the same mutation (Thr47-->Ala) and 18 had the wild-type sequence. For the three Thr47-->Ala mutants PZA MICs were 12.5 mu g/ml by the method of proportions on 7H10 agar; two of these were resistant to 100 mu g of PZA per ml and the third was resistant to 800 mu g of PZA per ml by the BACTEC method. In all, 30 different pncA mutations were found among the 37 pncA mutants. No PZase activity was detected in 35 of 37 strains that were resistant to greater than or equal to 100 mu g of PZA per ml or in 34 of 37 pncA mutants. Reduced PZase activity was found in the three mutants with the Thr47-->Ala mutation. This study demonstrates that mutations in the pncA gene may serve as a reliable indicator of resistance to greater than or equal to 100 mu g of PZA per ml.
引用
收藏
页码:2291 / 2295
页数:5
相关论文
共 31 条
[1]   TREATMENT OF TUBERCULOSIS AND TUBERCULOSIS INFECTION IN ADULTS AND CHILDREN [J].
BASS, JB ;
FARER, LS ;
HOPEWELL, PC ;
OBRIEN, R ;
JACOBS, RF ;
RUBEN, F ;
SNIDER, DE ;
THORNTON, G .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 149 (05) :1359-1374
[2]   Changing practices in mycobacteriology: A follow-up survey of state and territorial public health laboratories [J].
Bird, BR ;
Denniston, MM ;
Huebner, RE ;
Good, RC .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (03) :554-559
[3]   SUSCEPTIBILITY OF MYCOBACTERIUM-TUBERCULOSIS TO PYRAZINAMIDE AND ITS RELATIONSHIP TO PYRAZINAMIDASE ACTIVITY [J].
BUTLER, WR ;
KILBURN, JO .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (04) :600-601
[4]  
CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21
[5]  
Centers for Disease Control (CDC), 1992, MMWR-MORBID MORTAL W, V41, P507
[6]   pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis:: Spread of a monoresistant strain in Quebec, Canada [J].
Cheng, SJ ;
Thibert, L ;
Sanchez, T ;
Heifets, L ;
Zhang, Y .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (03) :528-532
[7]   TRANSMISSION OF MULTIDRUG-RESISTANT MYCOBACTERIUM-TUBERCULOSIS AMONG PERSONS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION IN AN URBAN HOSPITAL - EPIDEMIOLOGIC AND RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISM ANALYSIS [J].
CORONADO, VG ;
BECKSAGUE, CM ;
HUTTON, MD ;
DAVIS, BJ ;
NICHOLAS, P ;
VILLAREAL, C ;
WOODLEY, CL ;
KILBURN, JO ;
CRAWFORD, JT ;
FRIEDEN, TR ;
SINKOWITZ, RL ;
JARVIS, WR .
JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (04) :1052-1055
[8]   A multi-institutional outbreak of highly drug-resistant tuberculosis - Epidemiology and clinical outcomes [J].
Frieden, TR ;
Sherman, LF ;
Maw, KL ;
Fujiwara, PI ;
Crawford, JT ;
Nivin, B ;
Sharp, V ;
Hewlett, D ;
Brudney, K ;
Alland, D ;
Kreiswirth, BN .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (15) :1229-1235
[9]   QUALITY-CONTROL OF INDIVIDUAL COMPONENTS USED IN MIDDLEBROOK 7H10 MEDIUM FOR MYCOBACTERIAL SUSCEPTIBILITY TESTING [J].
GUTHERTZ, LS ;
GRIFFITH, ME ;
FORD, EG ;
JANDA, JM ;
MIDURA, TF .
JOURNAL OF CLINICAL MICROBIOLOGY, 1988, 26 (11) :2338-2342
[10]   PYRAZINAMIDE STERILIZING ACTIVITY INVITRO AGAINST SEMIDORMANT MYCOBACTERIUM-TUBERCULOSIS BACTERIAL-POPULATIONS [J].
HEIFETS, L ;
LINDHOLMLEVY, P .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 145 (05) :1223-1225